Latest in Wegovy Sales Beat
Sort by
975 items
-
Novo Nordisk's Wegovy Sales Beat Expectations
The pharmaceutical giant narrowed its full-year guidance after its blockbuster Wegovy weight-loss drug beat sales expectations in the third quarter.Business - The Wall Street Journal - 6 hours ago -
Novo Nordisk shares jump 8% after Wegovy sales beat expectations
Novo Nordisk on Wednesday reported third quarter earnings broadly in line with expectations and narrowed its 2024 full-year growth guidance.Business - CNBC - 5 hours ago -
Danone Sales Growth Beats Market Expectations
The French food company confirmed its full-year guidance after a strong performance in North America and robust growth in sales volumes helped it deliver higher-than-expected organic revenue growth ...Business - The Wall Street Journal - October 24 -
BYD quarterly sales beat Tesla for first time
Warren Buffett-backed Chinese carmaker’s revenues surge 24 per cent but fierce competition slims marginsBusiness - Financial Times - 6 days ago -
Johnson & Johnson’s stock falls despite Q3 sales beat and guidance raise
Johnson & Johnson reported better-than-expected third-quarter sales and raised its full-year revenue guidance.Business - MarketWatch - October 15 -
Hizbollah warns of escalation in Israel conflict after Yahya Sinwar killing
Threat from Lebanese militant group follows death of Hamas leader in firefight in GazaBusiness - Financial Times - October 18 -
British retail sales beat forecasts to rise for third straight month
Tech purchases fuel unexpected growth of 0.3%Business - Financial Times - October 18 -
Procter & Gamble earnings beat estimates, but weak demand in China hurts sales
Procter & Gamble said volume fell in its Greater China market despite the earnings beat.Business - CNBC - October 18 -
GE Aerospace’s stock sinks as total sales beat, but commercial engines miss
GE Aerospace beats earnings expectations but its largest business, commercial engines, missed revenue expectations and the stock pulled back from a 17-year highBusiness - MarketWatch - October 22 -
Boston Scientific’s stock climbs on Q3 sales and earnings beat
Medical-products company Boston Scientific reported third-quarter results before market open.Business - MarketWatch - October 23 -
Honeywell’s stock falls as sales miss and lowered guidance offsets profit beat
Honeywell International Inc.’s stock fell 2.5% early Thursday, after the aerospace and technology company missed third-quarter sales estimates and lowered its guidance, offsetting a profit beat.Business - MarketWatch - October 24 -
McDonald's reverses U.S. same-store sales declines in the third quarter, but E. coli fallout looms
Shares of McDonald's have fallen 6% since its Quarter Pounder burgers were linked to a deadly E. coli outbreak.Business - CNBC - October 29 -
Apple cautious on holiday outlook as it starts AI rollout
Shares fall despite solid earnings as analysts weigh impact of new ‘Apple Intelligence’ featuresBusiness - Financial Times - 4 days ago -
Ericsson shares jump 10% on third-quarter beat, growth in North America sales
Shares of Swedish telecom firm Ericsson jumped amid third-quarter core earnings that surpassed analyst expectations and growth North American demand.Business - CNBC - October 15 -
Abbott Labs beats Q3 sales and earnings expectations, raises full-year outlook
Abbott Laboratories on Wednesday reported better-than-expected third-quarter earnings and sales, boosted by strength in the company’s medical-devices business.Business - MarketWatch - October 16 -
Procter & Gamble’s stock slips as profit beat, steady outlook offset a sales miss
Shares of Procter & Gamble Co. fell 1.2% in premarket trading Friday, after the consumer packaged-goods company reported fiscal first-quarter profit that beat expectations and maintained its ...Business - MarketWatch - October 18 -
UPS beat on revenue for the first time in 2 years, even as online sales slowed
UPS’s stock jumps toward a three-month high after earnings beat expectations, with revenue topping forecasts for the first time in nine quarters.Business - MarketWatch - October 24 -
Reddit’s stock soars after social-media platform turns a profit, beats Q3 sales and earnings estimates
Reddit said Tuesday that it turned a profit in its third quarter — a first for the social-media platform since becoming a public company earlier this year.Business - MarketWatch - October 30 -
Georgia election official appeals to Musk over foreign disinformation on X
Brad Raffensperger says viral post alleging repeat voting in US state is likely from ‘Russian troll farms’World - Financial Times - 5 days ago -
Low-volatility ETFs lose favour as investors jump to buffered peers
Despite poor returns in recent years, analysts say people could be missing out on their long-term investment potentialWorld - Financial Times - 5 days ago -
Weight loss injections: How do drugs like Wegovy and Mounjaro work?
NHS experts report unprecedented demand for the new generation of obesity treatments.Top stories - BBC News - October 18 -
Ozempic and Wegovy Ease Knee Osteoarthritis Pain in Large Study
A large trial showed that semaglutide, sold as Ozempic for diabetes and as Wegovy for obesity, was better than any current medications in alleviating symptoms.Health - The New York Times - 5 days ago -
Ozempic and Wegovy considered 'available' after more than 2 years in shortage
The diabetes and weight loss medications Ozempic and Wegovy are now considered to be available after more than two years of being considered in shortage by the Food and Drug Administration (FDA). ...Politics - The Hill - 6 days ago -
Wegovy's creator invested £6bn in this town. So why is it not booming?
Europe's most valuable company has invested billions in Kalundborg on Denmark's coast - but it has many problems.Top stories - BBC News - 3 days ago -
The Novo Nordisk scientist behind Ozempic, Wegovy weight loss research
Drugs Ozempic and Wegovy have slimmed down Hollywood stars — and millions of non-celebrities worldwide — while adding great heft to the economy of Novo Nordisk’s home country, Denmark.Top stories - CBS News - 2 days ago -
How a love story launched the company behind Ozempic, Wegovy
Novo Nordisk, the pharma giant behind Ozempic and Wegovy, has surprising love story origins. The founders, a married couple, were looking for a way to tackle diabetes, which the wife suffered from.Top stories - CBS News - 2 days ago -
Novo Nordisk asks FDA to ban compounding pharmacies from making Ozempic, Wegovy copies
The Danish drugmaker Novo Nordisk argues that semaglutide, the active ingredient in Ozempic and Wegovy, are too complex for those manufacturers to make safely.Business - CNBC - October 23 -
Novo Nordisk's Ozempic and Wegovy now available in the U.S. after shortages, FDA says
It is a sign that Novo Nordisk's efforts to ramp up the supply of those drugs are starting to pay off, as demand continues to skyrocket in the U.S.Business - CNBC - 6 days ago -
Corporate Germany is on sale
German companies have become relatively small and relatively cheapWorld - Financial Times - October 18 -
Mattel Lowers Sales Outlook After Barbie Sales Weigh
The toy company’s profit, however, is holding up due to stronger margins, helped by factors such as cost cuts, supply-chain improvements and lower input costs.Business - The Wall Street Journal - October 23 -
How to Turn a Sales Blunder Into a Win
With two decades in sales behind him, Pushly CEO Brendan Ripp has plenty of advice.Business - Inc. - October 14 -
Starbucks Shares Drop After Dismal Preliminary Quarterly Earnings
“We need to fundamentally change our strategy,” the coffee giant’s new chief executive said.Business - The New York Times - October 23 -
Roche Increases Dividend on Higher Sales
Roche said it would increase its dividend after its hemophilia injection Hemlibra and multiple sclerosis treatment Ocrevus lifted sales in the first nine months of the year.Business - The Wall Street Journal - October 23 -
Don’t Overlook This Sales-Growth Superpower
Inc.’s editor-in-chief reveals the channel that powers many of the fastest-growing companies in America.Business - Inc. - October 25